Recommendations and Guidelines:
ACIP Presentation Slides: October 2011 Meeting
ACIP topics:
On this page:
October 25, 2011
- Welcome
- Human Papillomavirus Vaccine (HPV)
- Child/Adolescent Immunization Schedule
- Adult Immunization Schedule
- Hepatitis B Vaccine
- Meningococcal Vaccine (MCV)
- Public Engagement
October 25, 2011
Welcome
- Opening Remarks
[PDF - 275KB, 4 pages]
Dr. L Pickering
Human Papillomavirus Vaccine (HPV)
- Introduction [PDF - 319KB, 7 pages]
Dr. J Bocchini - Safety of Quadrivalent Human Papillomavirus (HPV4) Vaccine [PDF - 609KB, 29 pages]
Ms. J Gee - Post-licensure Safety Study of Quadrivalent Human Papillomavirus Vaccine among 189,629 Females [PDF - 336KB, 20 pages]
Dr. C Velicer - HPV Vaccine for Males Background and Review of Data [PDF - 1.8MB, 63 pages]
Dr. L Markowitz - HPV Vaccine Considerations for Males [PDF - 577KB, 49 pages]
Dr. E Dunne - VFC Resolution Update: HPV Vaccines [PDF - 353KB, 10 pages]
Dr. J Santoli
Child/Adolescent Immunization Schedule
- 2012 Immunization Schedules for Children 0 Through 18 Years of Age [PDF - 2.5MB, 47 pages]
Dr. C Meissner
Adult Immunization Schedule
- Adult Immunization Schedule, 2012 [PDF - 892KB, 24 pages]
Dr. C Bridges
Hepatitis B Vaccine
- Introduction [PDF - 281KB, 7 pages]
Dr. M Sawyer - Odds of Acute Hepatitis B Among Persons with Diabetes at Eight Emerging Infection Program Sites [PDF - 139KB, 31 pages]
Dr. S Schillie - Hepatitis B Vaccination for Adults with Diabetes: Summary of Considerations [PDF - 814KB, 28 pages]
Dr. T Murphy - Assisted Blood Glucose Monitoring [PDF - 793KB, 18 pages]
Dr. P Allweiss - Implementation of Hepatitis B Vaccination for Adults with Diabetes [PDF - 463KB, 16 pages]
Dr. K Byrd - GRADE: Hepatitis B Vaccination among Adults with Diabetes [PDF - 692KB, 46 pages]
Dr. S Schillie - Hepatitis B Vaccination for Adults with Diabetes [PDF - 390KB, 19 pages]
Dr. T Murphy
Meningococcal Vaccines
- Introduction [PDF - 399KB, 16 pages]
Dr. A Cohn - Epidemiology of Meningococcal Disease In Infants and Young Children [PDF - 364KB, 5 pages]
J MacNeil - Cost-Effectiveness of Meningococcal Vaccination in Infants and Toddlers in the United States [PDF - 290KB, 37 pages]
Dr. I Ortega-Sanchez - Considerations for Use of Meningococcal Conjugate Vaccines in Infants and Toddlers [PDF - 624KB, 31 pages]
Dr. A Cohn - Stakeholder and Public Engagement: Meningococcal Vaccines and Infants [PDF - 808KB, 36 pages]
Dr. G Nowak
October 26, 2011
13-valent Pneumococcal Conjugate Vaccine (PCV13)
- Introduction [PDF - 498KB, 8 pages]
Dr. M Marcy - Prevention of Pneumococcal Disease Among Immunocompromised Adults [PDF - 797KB, 33 pages]
Dr. K Dooling
General Recommendations/Febrile Seizures
- Introduction [PDF - 1410KB, 14 pages]
Dr. J Duchin
Pertussis
- Pertussis Vaccines Working Group Update [PDF - 475KB, 5 pages]
Dr. M Sawyer
Immunization Coverage
- Child and Adolescent Vaccination Coverage Levels: 2010 NIS [PDF - 746KB, 35 pages]
Dr. L Rodewald
Vaccine Supply
- Vaccine Supply Update [PDF - 352KB, 6 pages]
Dr. J Santoli
Measles
- Introduction [PDF - 417KB, 4 pages]
Dr. J Temte - Epidemiology of Measles in the United States [PDF - 341KB, 19 pages]
Dr. H McLean - Mexico’s Measles Control Efforts [PDF - 1727KB, 12 pages]
Dr. V Richardson - Use of MMR vaccine among persons with HIV infection [PDF - 676KB, 12 pages]
Dr. G Siberry - Considerations for use of MMR vaccine among persons with HIV infection [PDF - 197KB, 5 pages]
Dr. H McLean
Influenza
- Introduction [PDF - 782KB, 9 pages]
Dr. W Keitel - Influenza Activity Update [PDF - 1578KB, 6 pages]
Dr. L Grohskopf - Adverse Events following Fluzone® High-Dose Reported to the VAERS, United States 2010-2011 [PDF - 417KB, 25 pages]
Dr. P Moro - Influenza Vaccination Distribution and Coverage, United States, 2010-11 and 2011-12 Seasons [PDF - 1463KB, 30 pages]
J Singleton - Effectiveness of US 2010-11 influenza vaccines in preventing RT-PCR-confirmed medically attended influenza infections [PDF - 50KB, 21 pages]
Dr. M Thompson
*Accessibility Note: For text-only versions of these files for screen-reader device compatibility, contact NIPINFO@cdc.gov for immediate assistance.
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
This page last modified on November 7, 2011
Content last reviewed on November 7, 2011
Content Source: National Center for Immunization and Respiratory Diseases
